Chorda Pharma Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$200K
- Investors
-
3
Chorda Pharma General Information
Description
Operator of a pharmaceutical company intended to treat arthritis, diabetic neuropathy, sports injuries, and other ailments requiring long-term treatment to relieve pain. The company's medications are opioid-free and are used as an alternative to traditional prescription-based pain relievers, like opioids, and provide a pipeline of proprietary analgesics for managing chronic pain, enabling patients to get treated without having to consume harmful drugs and pain relievers.
Contact Information
Website
www.chordapharma.comCorporate Office
- 709 South Jefferson Street
- Suite 301
- Roanoke, VA 24016
- United States
Corporate Office
- 709 South Jefferson Street
- Suite 301
- Roanoke, VA 24016
- United States
Chorda Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Angel (individual) | 20-Dec-2024 | $200K | Completed | Generating Revenue | ||
| 3. Grant | 27-Jun-2022 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 26-Apr-2022 | $292K | $312K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 15-May-2018 | $20K | $20K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Chorda Pharma Patents
Chorda Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4733295-A1 | Stable forms of capsaicin palmitate for the treatment of pain | Pending | 25-Oct-2024 | ||
| JP-2026077618-A | Stable forms of capsaicin palmitate for the treatment of pain | Pending | 25-Oct-2024 | ||
| US-12458611-B1 | Stable forms of capsaicin palmitate for the treatment of pain | Active | 25-Oct-2024 | ||
| US-20260115155-A1 | Stable forms of capsaicin palmitate for the treatment of pain | Pending | 25-Oct-2024 | ||
| WO-2024243507-A2 | Solid forms of capsaicin palmitate for the treatment of pain | Inactive | 24-May-2023 | C07C53/126 |
Chorda Pharma Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Common Wealth Angels | Angel Group | Minority | ||
| Virginia Innovation Partnership Corporation | Not-For-Profit Venture Capital | |||
| Regional Accelerator & Mentoring Program | Accelerator/Incubator |
Chorda Pharma FAQs
-
When was Chorda Pharma founded?
Chorda Pharma was founded in 2018.
-
Where is Chorda Pharma headquartered?
Chorda Pharma is headquartered in Roanoke, VA.
-
What industry is Chorda Pharma in?
Chorda Pharma’s primary industry is Drug Discovery.
-
Is Chorda Pharma a private or public company?
Chorda Pharma is a Private company.
-
What is Chorda Pharma’s current revenue?
The current revenue for Chorda Pharma is .
-
How much funding has Chorda Pharma raised over time?
Chorda Pharma has raised $512K.
-
Who are Chorda Pharma’s investors?
Common Wealth Angels, Virginia Innovation Partnership Corporation, and Regional Accelerator & Mentoring Program have invested in Chorda Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process